Journal of Molecular Structure, Journal Year: 2024, Volume and Issue: 1326, P. 141092 - 141092
Published: Dec. 13, 2024
Language: Английский
Journal of Molecular Structure, Journal Year: 2024, Volume and Issue: 1326, P. 141092 - 141092
Published: Dec. 13, 2024
Language: Английский
Bioorganic Chemistry, Journal Year: 2025, Volume and Issue: 159, P. 108357 - 108357
Published: March 10, 2025
Language: Английский
Citations
0Journal of Molecular Structure, Journal Year: 2025, Volume and Issue: unknown, P. 142213 - 142213
Published: March 1, 2025
Language: Английский
Citations
0Molecular Diversity, Journal Year: 2025, Volume and Issue: unknown
Published: Feb. 22, 2025
Abstract Two new series of pyrimidinyl ethyl pyrazoles derivatives 13a–f and 14a–f were designed synthesized to possess both anticancer effect by inhibiting BRAFV600E anti-inflammatory JNK isoforms. The structure the compounds was generated from hybridization two main moieties. moiety reported inhibitors, pyrazole isoforms inhibitors. final tested on BRAFV600E, JNK1, JNK2, JNK3 measure their kinases inhibitory effect. Compound 14c showed highest activity with IC 50 = 0.51 μM, 0.53 1.02 0.009 μM JNK3,and respectively. All over four cancer cell lines related target enzymes. 14d most potent all 0.87 0.91, 0.42 0.63 MOLT-4, K-562, SK-MEL-28, A375 lines, ability inhibit MEK1/2 ERK1/2 phosphorylation performed using western blot. cycle analysis compound line revealed that arrested growth at G0-G1 phase. remarkably decreased migration compared control group in traditional test. Compounds significant nitric oxide release PGE2 production raw 264.7 macrophages. 13d 1 4d exhibited high iNOS COX-2 COX-1. Finally, TNF-alpha IL-6 determined. Graphical abstract synthesized. able BRAFV600E. play a key role inflammatory disorders. Final for activities.
Language: Английский
Citations
0Journal of Molecular Structure, Journal Year: 2024, Volume and Issue: 1326, P. 141092 - 141092
Published: Dec. 13, 2024
Language: Английский
Citations
1